Evidence map›Paper›PMID 28725008›Full record

ArticleScientific reports2017

Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds.

Mohammad Hassan Baig, Arif Tasleem Jan, Gulam Rabbani, Khurshid Ahmad, Jalaluddin M Ashraf, Taeyeon Kim, Han Sol Min, Yong Ho Lee, Won-Kyung Cho, Jin Yeul Ma and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Effect ofHeliyon · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Mohammad Hassan BaigDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Arif Tasleem JanDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Gulam RabbaniDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Khurshid AhmadDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.ORCID 0000-0002-1095-8445
Jalaluddin M AshrafDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Taeyeon KimDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Han Sol MinDepartment of Biomedical Science, Catholic University of Daegu, Gyeongsan, 38430, Republic of Korea.
Yong Ho LeeDepartment of Biomedical Science, Catholic University of Daegu, Gyeongsan, 38430, Republic of Korea.
Won-Kyung ChoKorean Medicine (KM) Application Center, Korea Institute of Oriental Medicine (KIOM), Dong-gu, Daegu, 41062, Republic of Korea.
Jin Yeul MaKorean Medicine (KM) Application Center, Korea Institute of Oriental Medicine (KIOM), Dong-gu, Daegu, 41062, Republic of Korea.
Eun Ju LeeDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea. gorapadoc0315@hanmail.net.
Inho ChoiDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan, 38541, Republic of Korea. inhochoi@ynu.ac.kr.
Yeungnam University · KRDaegu Catholic University · KRKorea Institute of Oriental Medicine · KRYeungnam University Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes, MG increased oxidative stress and reduced myotube formation in C2C12 cells. RAGE (receptor for AGEs) expression was up-regulated and MYOD and myogenin (MYOG) expressions were concomitantly down-regulated in MG-treated cells. Interestingly, AGE levels were higher in plasma (~32 fold) and muscle (~26 fold) of diabetic mice than in control mice. RAGE knock-down (RAGE

Indexed as

AnimalsBiological ProductsCatecholsCell DifferentiationCell LineComputer SimulationCurcuminDiabetes Mellitus, ExperimentalFatty AlcoholsGene Expression RegulationGene Knockdown TechniquesGlycation End Products, AdvancedMice, Inbred C57BLMuscle DevelopmentMyostatinPyruvaldehydeBiological ProductsCatecholsCurcuminFatty AlcoholsgingerolGlycation End Products, AdvancedMyostatinPyruvaldehydeReceptor for Advanced Glycation End ProductsRNA, Messenger

Identifiers

PMID28725008
PMCPMC5517486
OpenAlexW2735990000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.